ADPT Adaptive Biotechnologies Corporation
Healthcare$14.10+0.00%OpenMarket Cap: $2.26B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$21.25
Target (Median)
$21.00
Target Range
$21.00 - $22.00
Upside from current price: 50.7%
Rating Distribution
2 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-05-06 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-06 | Guggenheim | maintain | Buy | Buy |
| 2026-05-06 | TD Cowen | maintain | Buy | Buy |
| 2026-05-06 | BTIG | maintain | Buy | Buy |
| 2026-02-06 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-06 | BTIG | maintain | Buy | Buy |
| 2026-01-26 | Guggenheim | maintain | Buy | Buy |
| 2025-11-11 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-11-06 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.25 | $350.3M | 6 |
| Sun Dec 31 | $-0.11 | $427.7M | 5 |
| Mon Dec 31 | $0.05 | $524.9M | 1 |
| Tue Dec 31 | $0.01 | $658.0M | 1 |